Chemcon Speciality Chemicals Ltd

About Chemcon Speciality Chemicals Ltd

Chemcon Speciality Chemicals Ltd. is a leading manufacturer of specialty chemicals in India, primarily focusing on Pharma Intermediates and Oilfield Chemicals. It holds a significant global market share in products like HMDS and CMIC, serving critical raw material needs for pharmaceutical, agrochemical, and oil & gas industries.

Key Financial Ratios of Chemcon Speciality Chemicals Ltd

• P/E Ratio (TTM): Price to Earnings ratio shows how much an investor pays for every rupee of the company's earnings. Chemcon Speciality Chemicals Ltd's P/E ratio (TTM) is 31.54, compared to the industry median of 31.54 and large cap median of 29.58.

• P/B Ratio: Price to Book ratio compares a company's market price to its book value per share. Chemcon Speciality Chemicals Ltd's P/B ratio is 1.54, compared to the industry median of 2.55 and large cap median of 2.31.

• P/S Ratio: Price to Sales ratio compares a company's market value to its total revenue. Chemcon Speciality Chemicals Ltd's P/S ratio is 3.16, compared to the industry median of 2.29 and large cap median of 1.93.

• PEG Ratio: PEG ratio adjusts the P/E ratio for expected earnings growth. Chemcon Speciality Chemicals Ltd's PEG ratio is 1.05.

• EV/EBITDA Ratio: This ratio compares a company's enterprise value to its earnings before interest, tax, depreciation, and amortization. Chemcon Speciality Chemicals Ltd's EV/EBITDA ratio is 13.41.

• Return on Equity (ROE): ROE measures how much profit a company generates from shareholders' invested capital. Chemcon Speciality Chemicals Ltd's ROE is N/A.

• Return on Assets (ROA): ROA measures how efficiently a company converts its assets into net profit. Chemcon Speciality Chemicals Ltd's ROA is N/A.

• Return on Capital Employed (ROCE): ROCE measures how efficiently a company generates profit from all the capital it employs. Chemcon Speciality Chemicals Ltd's ROCE is 6%.

• Operating Margin: Operating margin shows what percentage of revenue remains after covering operating expenses. Chemcon Speciality Chemicals Ltd's operating margin is 12.50%.

• Net Margin: Net margin shows what percentage of revenue converts into final net profit. Chemcon Speciality Chemicals Ltd's net margin is 10%.

• Current Ratio: The current ratio measures a company's ability to pay short-term liabilities using short-term assets. Chemcon Speciality Chemicals Ltd's current ratio is N/A.

• Debt to Equity Ratio: This ratio shows the proportion of debt a company uses relative to shareholders' equity. Chemcon Speciality Chemicals Ltd's debt-to-equity ratio is N/A.

• Interest Coverage Ratio: This ratio shows how easily a company can pay interest on its outstanding debt from its operating earnings. Chemcon Speciality Chemicals Ltd's interest coverage ratio is 17.

• Dividend Per Share (DPS): DPS shows the total dividend paid per share in the latest financial year. Chemcon Speciality Chemicals Ltd's DPS is ₹6.50.

• Earnings Per Share (EPS): EPS shows how much profit is allocated to each outstanding share. Chemcon Speciality Chemicals Ltd's EPS is -3.45.

(Source line: "Ratios as of 24 Jun 2026, based on last traded price of ₹203.14. Data sourced from BSE/NSE Exchange Filings & Public Terminal Data.")

Key Facts

• Founded: 1988
• Headquarters: Vadodara, Gujarat
• Core Offerings: Hexamethyldisilazane (HMDS), Chloromethyl Isopropyl Carbonate (CMIC), Bromine derivatives, Oilfield chemicals
• Stock Listing: NSE (CHEMCON), BSE (543233)
• Promoter: Kamalkumar Rajendra Aggarwal and Naresh Vijaykumar Goyal

History of Chemcon Speciality Chemicals Ltd

1988: Incorporated as Chemcon Speciality Chemicals Private Limited in Vadodara, Gujarat. 1990: Commenced commercial operations with the manufacturing of Hexamethyldisilazane (HMDS). 2000s: Expanded product portfolio to include Chloromethyl Isopropyl Carbonate (CMIC) and various oilfield chemicals. 2020: Converted to a public limited company and successfully completed an Initial Public Offering (IPO) on NSE and BSE. Present: Continues to be a key global supplier of specialty chemicals, known for its focus on quality and R&D.

Business Segments and Revenue Mix

• Pharma Intermediates: Manufactures key pharmaceutical intermediates like Hexamethyldisilazane (HMDS) and Chloromethyl Isopropyl Carbonate (CMIC), crucial for producing antiretroviral, anti-diabetic, and anti-fungal drugs, and also used as silylation agents.
• Oilfield Chemicals: Produces high-performance Completion Fluids for the oil & gas industry, primarily utilized in exploration and production activities to enhance well productivity and reservoir integrity.

Key Personnel

Mr. Naresh Vijaykumar Goyal - Whole-time Director & CEO. He is a co-promoter and instrumental in business development and operational management. Mr. Kamalkumar Rajendra Aggarwal - Whole-time Director & CFO. As a co-promoter, he brings extensive experience in the chemical industry and oversees financial operations.

Subsidiaries and Associate Companies

No major subsidiaries reported.

Corporate Actions

No major recent corporate actions on record.

References

1. Annual Report FY23 2. Exchange Filings (NSE/BSE) 3. Financial Results Announcement